Details of the Drug
General Information of Drug (ID: DMGE3N3)
Drug Name |
GP-531
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
GP-531; UK37HM0CDG; UNII-UK37HM0CDG; GP531; GP 531; AC1L4USD; AC1Q5G0X; 142344-87-4; SCHEMBL4885021; HY-U00116; CS-7153; 5-Amino-1-beta-D-(5'-benzylamino-5'-deoxyribofuranosyl)imidazole-4-carboxamide; 5-amino-1-[5-(benzylamino)-5-deoxy-; A-d-ribofuranosyl]-1h-imidazole-4-carboxamide; 5-amino-1-[(2R,3R,4S,5R)-5-[(benzylamino)methyl]-3,4-dihydroxyoxolan-2-yl]imidazole-4-carboxamide; 1H-Imidazole-4-carboxamide, 5-amino-1-(5-deoxy-5-((phenylmethyl)amino)-beta-D-ribofuranosyl)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||